Indicators of the quality of life in women with Graves’ disease after radioactive iodine treatment
Journal Title: Міжнародний ендокринологічний журнал - Year 2018, Vol 14, Issue 2
Abstract
Background. The purpose of the research was to evaluate the quality of life in women with Graves’ disease after radioactive iodine therapy. Materials and methods. We have examined 79 women with Graves’ disease after radioactive iodine treatment. The first group included 23 patients in euthyroid state, the second one — 56 women with hypothyroidism. The control group consisted of 15 women without thyroid pathology. Results. Women with Graves’ disease had a deterioration in the quality of life manifested by low indexes of both physical (by 30.3 %) and psychological (by 26.6 %) components of health. Conclusions. After radioactive iodine therapy, there was a significant improvement in the quality of life in women with Graves’ disease, and the total physical component increased by 38.2 %, psychological — by 33.4 %. Before treatment, the quality of life of women with Graves’ disease was significantly lower compared to the control group.
Authors and Affiliations
U. Z. Mirzaeva, Kh. R. Gulyamova
Keywords
Related Articles
- EP ID EP299505
- DOI 10.22141/2224-0721.14.2.2018.130561
- Views 97
- Downloads 0
Management of Diabetic Neuropathy: Focus on Patient
The article highlights the questions of pathogenesis and treatment of diabetic neuropathy — one of the most frequent complications of diabetes mellitus. The effects of alpha-lipoic acid — first-line drug in the treatment...
Prevalence of Оsteoporosis and Low Bone Mineral Density in Ukrainian Women with Obesity and Metabolic Syndrome
Objective: to determine the incidence of osteoporosis and low bone mineral density (BMD) in Ukrainian women with obesity and metabolic syndrome. Materials and methods. The study involved 1,605 persons, whose mean age was...
New Opportunities in Prevention of Diabetes Mellitus Type 2
.
Economic Efficiency of Neonatal Screening for Congenital Adrenal Hyperplasia in Ukraine
In 2012, neonatal screening (NS) for congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency has been introduced in Ukraine. For a year, as part of the screening we have examined 493,580 newborns. In total,...
Efficacy of Balanced Vitamin B Complex Use in Treatment of Diabetic Polyneuropathy
No abstract